Quality of Life After Myocardial Infarction
Quality of Life After Myocardial Infarction: The Impact of Social Support
調査の概要
状態
条件
詳細な説明
Primary objectives:
Our primary objective is to determine among patients hospitalized for a myocardial infarction, the impact of emotional support on functional outcomes at two years as measured by a valid measure of functional health, the SF-36.
Secondary Objectives:
Our secondary objectives are:
- To determine the types of social support which are perceived as being most helpful to patients.
- To determine whether women and minority patients have unique views on the types of support that are helpful.
- To determine among patients admitted for myocardial infarction, the impact of social support on length of stay and hospital readmissions.
Hypothesis:
Our hypotheses are as follows:
- Patients who are hospitalized for a myocardial infarction and who have high emotional support will have better long-term functional status compared to those patients who have low support.
- Patients with high emotional support will be more likely to adhere to protocols such as taking their medications, keeping appointment, and enrolling in cardiac rehabilitation.
- Patients with high emotional support will have lengths of hospitalization which are shorter than their estimated geometric mean as compared to patients who have low support.
- The types of social support which are perceived as most helpful in disease management will be influenced by gender and ethnicity.
Long-term Objectives:
The long-term objective is to determine the mechanisms by which social support impacts on functional health and to utilize this data to develop future interventions that can be targeted toward a culturally and ethically diverse cohort of patients with coronary artery disease. Overall, the goal is to use this data to prevent functional disability and improve quality of life among patients with coronary artery disease.
研究の種類
入学 (予想される)
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
- Patients who have had a documented myocardial infarction by EKG and laboratory criteria will be eligible. The attending cardiologist of these patients will be approached. Once the attending cardiologist declares that a patient is clinically stable enough for participation, they will be approached, told about the study, and asked if they wish to participate.
研究計画
研究はどのように設計されていますか?
デザインの詳細
協力者と研究者
捜査官
- 主任研究者:Carla Boutin-Foster, MD、Joan and Sanford I. Weill Medical College
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。